ZS Pharma (FRA:0ZS) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is ZS Pharma Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

ZS Pharma's cash flow from discontinued operations for the three months ended in Sep. 2015 was €0.00 Mil. It means ZS Pharma received €0.00 Mil from the sale of part of business quarterly. ZS Pharma's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2015 was €0.00 Mil.

ZS Pharma Cash Flow from Discontinued Operations Historical Data

The historical data trend for ZS Pharma's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZS Pharma Cash Flow from Discontinued Operations Chart

ZS Pharma Annual Data

Trend

Dec12

Dec13

Dec14

Cash Flow from Discontinued Operations

ZS Pharma Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial							-	-	-	-	-

ZS Pharma Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

ZS Pharma Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of ZS Pharma's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

ZS Pharma (FRA:0ZS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZS Pharma Inc (FRA:0ZS) » Definitions » Cash Flow from Discontinued Operations

Traded in Other Exchanges

N/A

Address

Website

http://www.zspharma.com

ZS Pharma Inc was incorporated in Delaware in February 2008. The Company is a biopharmaceutical company engaged in the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It was initially engaged in the development of ZS-9, its product candidate in Phase 3 development for the treatment of hyperkalemia. Hyperkalemia is characterized by elevated levels of potassium in the blood (greater than 5.0 mEq/L) and is a life-threatening condition that occurs frequently in patients with chronic kidney disease (CKD), heart failure, and diabetes. ZS-9 is currently in Phase 3 clinical development. ZS-9 is a therapy to treat hyperkalemia, regardless of the underlying cause, and allows patients to benefit from the cardio-renal protective effect of RAAS therapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that address CKD, HF and metabolic diseases. It faces competition from many pharmaceutical and biotechnology companies that are researching and selling products to treat CKD, HF and metabolic diseases. The Company is subject to numerous federal, state and local laws relating to such matters as safe working conditions, manufacturing practices, environmental protection, fire hazard control, and disposal of hazardous or potentially hazardous substances.

ZS Pharma (FRA:0ZS) Headlines

No Headlines